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Abstract: Infections caused by Salmonella serovars are the leading cause of foodborne hospitalizations
and deaths in Americans, extensively prevalent worldwide, and pose a considerable financial
burden on public health infrastructure and private manufacturing. While a comprehensive review
is lacking for delineating the role of dietary components on prevention of Salmonellosis, evidence
for the role of diet for preventing the infection and management of Salmonellosis symptoms is
increasing. The current study is an evaluation of preclinical and clinical studies and their underlying
mechanisms to elaborate the efficacy of bioactive dietary components for augmenting the prevention of
Salmonella infection. Studies investigating dietary components such as fibers, fatty acids, amino acids,
vitamins, minerals, phenolic compounds, and probiotics exhibited efficacy of dietary compounds
against Salmonellosis through manipulation of host bile acids, mucin, epithelial barrier, innate
and adaptive immunity and gut microbiota as well as impacting the cellular signaling cascades of
the pathogen. Pre-clinical studies investigating synergism and/or antagonistic activities of various
bioactive compounds, additional randomized clinical trials, if not curtailed by lack of equipoise
and ethical concerns, and well-planned epidemiological studies could augment the development
of a validated and evidence-based guideline for mitigating the public health burden of human
Salmonellosis through dietary compounds.
Keywords: dietary bioactive components; salmonellosis; bile acids; epithelial barrier; gut microbiota
1. Introduction
Despite increased awareness and development of treatments such as antimicrobial interventions
in manufacturing and antibiotic therapies in healthcare facilities for over a hundred years, Salmonella
serovars are still a major concern in infectious diseases related premature morbidity and mortality [1–4].
Various serovars of Salmonella are the leading cause of foodborne hospitalizations and deaths in
Americans causing over one million, about 20,000, and 378 annual illness, hospitalization, and deaths
episodes, respectively [5]. Non-typhoidal Salmonella serovars are also the leading agent among most
common foodborne infectious diseases, responsible for highest number (32,900 years) of disability
adjusted life year (DALY), annually [6]. National Antimicrobial Resistance Monitoring System (NARMS)
and other epidemiological sampling also reveal a widespread presence of multiple drug resistance
(MDR) phenotypes of the pathogen in various facilities—as an example, 0.6% of ground meat samples
may harbor MDR Salmonella [7] with approximately 7% of them displaying MDR-AmpC phenotype [8].
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As such, the U.S. Department of Health and Human Services had categorized non-typhoidal Salmonella
as a “serious threat” to the public health [9].
Data from world population also indicate that the pathogen is one of the leading causes of deaths
associated with diarrheal diseases globally, with estimated 3.4 million cases (invasive non-typhoidal
Salmonella serovars) and over 600,000 deaths annually [10,11]. The bacterium is a Gram-negative
organism with a complicated and evolving nomenclature, currently consist of two species, at least six
sub-species, and over 2500 serovars [12].
Changes in production and manufacturing practices, increased international commerce and travel,
increased proportion of at-risk populations for infectious diseases, and changes in population’s eating
habits during last few decades had contributed to increased incidences of Salmonella infections [13,14].
Salmonella serovars induce acute inflammation in the intestinal track after infection and utilizes the
environment to further proliferate and colonize [15–17]. Colonization resistance against Salmonella is
modulated by gut microflora, intestinal immunity, epithelium, and quality and quantity of digestive
fluids. Various food components have been shown to modulate these factors and could be a potential
intervention for reducing the likelihood of enteric infections.
Over the past 20 years, role of the dietary agents in shaping immunity against enteric infections has
becoming increasingly evident [18–22] and piqued the interest in nutritional interventions for enteric
infections. Several dietary components ranging from polyphenolic compounds, fibers, micronutrients,
fatty acids, peptides, and carbohydrates of plant and animal origin had been shown efficacious against
Salmonella serovars in various experimental models [22–32]. These associations are the result of an
array of potential biochemical pathways, very complex and dynamic in nature, including interactions
among dietary components, gut epithelium, digestive system, immune system and gut microbiota
as affected by various seasons [33–37]. Better understanding of these underlying mechanisms could
reduce Salmonella prevalence in the food chain though modifications in food animal diets. It could
further reduce the public health burden of non-typhoidal Salmonella serovars by mitigating severe
symptoms and reducing the pathogen DALY and mortality rate in healthcare facilities for Salmonellosis
patients. Hence, the current work is a review of Salmonella infection studies as affected by various
dietary components with discussions of the mechanisms of action and types of preclinical, animal
models, and clinical studies employed.
2. Current Status of Knowledge
2.1. Effect of Dietary Components against Salmonella: In-Vitro Models
Dietary components may prevent infection outcome by directly affecting the pathogen
multiplication and virulence [7,38,39] or by modulating host response to the pathogens [26,37].
To test the direct effects of dietary components on pathogens, researchers have used food extracts or
dietary bioactive components on Salmonella cultures. Summary of potential relationships between
dietary components and Salmonella infections are presented in Figure 1. Following treatment
of dietary components, multiplication, and gene expression for virulence and motility could be
measured. These models are comparatively less expensive and less cumbersome to assess the
efficacy of dietary components for Salmonella infection. For instance, several essential oils were
added to Salmonella growth media at various doses and Salmonella multiplication was compared with
untreated controls [38]. Among 28 tested essential oils, Origanum heracleoticum, Cinnamomum cassia,
Corydothymus capitatus, Satureja montana, and Cinnamomum verum were particularly effective against
Salmonella Typhimurium [38]. Citrus flavonoids were similarly evaluated on Salmonella virulence gene
expression [39]. In the study, Naringenin, a flavanone present in grapefruit, repressed 24 genes in
pathogenicity island of Salmonella Typhimurium LT2 and further down-regulated 17 genes associated
with the pathogen motility [39]. Most recent studies also reveal similar trends, for example, various
essential oils extracted from Aloysia triphylla, Cinnamomum zeylanicum, Cymbopogon citratus, Litsea
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cubeba, Mentha piperita, and Syzygium aromaticum had been shown to be efficacious against Salmonella
serovars during in vitro challenge studies [40].Microorganisms 2019, 7, x FOR PEER REVIEW 3 of 18 
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Orally infected Salmonella can enter circulation through various routes. It can invade several 
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invades both phagocytic and epithelial non-phagocytic cell types. Hence, in vitro models of Salmonella 
entry have been developed to assess the effect of a test compound on a host. The Salmonella entry 
model could reveal the mechanism of action of a test compound on an organism. Several human and 
mouse cell lines such as Caco-2 [41] and RAW264.7 have been used in the literature to test efficacy of 
the compounds against Salmonella entry. For example, secretory immunoglobulin A (SIgA) was 
demonstrated to be a potent inhibitor for Salmonella Typhimurium entry into polarized monolayers 
of HeLa cells [42]. 
Salmonella contains the pathogenicity islands for the secretion of effector molecules to infect the 
target cells [43]. The molecules released by these secretory systems change the host cell cytoskeleton 
to facilitate Salmonella entry. The in vitro Salmonella entry models are impactful in studying the effects 
of dietary components on Salmonella as well as on host cells. However, these studies do not represent 
involvement of all host cell types that are simultaneously present in gastrointestinal area of humans. 
Dietary components could affect Salmonella virulence by affecting secretory systems or by competing 
with Salmonella for the receptors on host cells [39]. Host cells can also release the cytokines in response 
to the dietary components that can affect Salmonella virulence or motility. Therefore, in vitro models 
of Salmonella infection can have great implications for assessing mechanisms of actions by the dietary 
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in rodents. Bovee-Oudenhoven et al. showed reduced Salmonella fecal shedding when 
fructooligosaccharides were fed to the male Wistar rats as compared to the cellulose-fed group after 
2 weeks of dietary intervention [44]. Furthermore, dietary fructooligosaccharides increased fecal 
Lactobacilli count and increased the translocation of Salmonella to the liver and spleen with an increase 
in fecal mucin as compared to cellulose fed rats [19]. The author concluded that dietary 
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i prove the gut epithelium, icrobiota, and immunity that may eventually lead to increased resistance
to Salmonella infection.
It is noteworthy that aforementioned studies are conducted without host interaction and
interpretation and generalization of the results should be drawn with caution and after further
investigations in presence of host cells.
Orally infected Salmonella can enter circulation through various routes. It can invade several
phagocytic and non-phagocytic cells depending upon serotype. In the murine model, Salmonella
invades both phagocytic and epithelial non-phagocytic cell types. Hence, in vitro models of Salmonella
entry have been developed to assess the effect of a test compound on a host. The Salmonella entry
model could reveal the mechanism of action of a test compound on an organism. Several human and
mouse cell lines such as Caco-2 [41] and RAW264.7 have been used in the literature to test efficacy
of the compounds against Salmonella entry. For example, secretory immunoglobulin A (SIgA) was
demonstrated to be a potent inhibitor for Salmonella Typhimurium entry into polarized monolayers of
HeLa cells [42].
Salmonella contains the pathogenicity islands for the secretion of effector molecules to infect the
target cells [43]. The molecules released by these secretory systems change the host cell cytoskeleton
to facilitate Salmonella entry. The in vitro Salmonella entry models are impactful in studying the
effects of dietary components on Salmonella as well as on host cells. However, these studies do not
represent involvement of all host cell types that are simultaneously present in gastrointestinal area of
humans. Dietary components could affect Salmonella virulence by affecting secretory systems or by
competing with Salmonella for the receptors on host cells [39]. Host cells can also release the cytokines
in response to the dietary components that can affect Salmonella virulence or motility. Therefore, in vitro
models of Salmonella infection can have great implications for assessing mechanisms of actions by the
dietary components.
2.2. Summary of Effect of Dietary Components on Salmonella Infection in Rodent Models
The fecal shedding of Salmonella, tissue colonization, local and systemic inflammatory changes,
survival and weight reduction are the major observable changes associated with Salmonella
infections in rodents. Bovee-Oudenhoven et al. showed reduced Salmonella fecal shedding when
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fructooligosaccharides were fed to the male Wistar rats as compared to the cellulose-fed group
after 2 weeks of dietary intervention [44]. Furthermore, dietary fructooligosaccharides increased
fecal Lactobacilli count and increased the translocation of Salmonella to the liver and spleen with an
increase in fecal mucin as compared to cellulose fed rats [19]. The author concluded that dietary
fructooligosaccharides decreased Salmonella colonization but increased the translocation potentially
due to irritation of mucosal membrane. Some of the mice strains succumb easily to Salmonella
infection and hence survival rate is the primary indicator of the dietary efficacy against infection.
Hitchins et al. showed that feeding of freeze dried yoghurt to male weanling Sprague-Dawley rats
increased overall survival rate and weight of the animals after intraperitoneal Salmonella challenge as
compared to rats fed on milk diet for 1 week [45]. Similarly, dietary feeding of Herba Pogostemonis
extract to Balb/c mice increased the overall survival rate as compared to control diet fed animals
after intraperitoneal Salmonella challenge [46]. Feeding of Herba Pogostemonis (Pogostemon cablin
Bantham extract) also reduced Salmonella liver damage as compared to control diet fed animals [46].
Recent studies similarly show association among various bioactive food compounds and prevention of
Salmonellosis. Supplementing the diet of albino rats with olive oil, as an example, had been shown to
have efficacy against Salmonella Typhi as a natural antimicrobial and non-toxic immune modulator [47].
These studies show that there are measurable markers for Salmonella infections in rodents and they can
be used as a model to mimic Salmonella infections in human host.
Both foodborne pathogens and dietary components pass through the stomach acid, when ingested.
Hence, gastric acidity is one of the important factors in determining stability of enteric pathogens. In a
randomized controlled clinical trial, gastric hypochlorhydria (low hydrochloric acid) was found to be
associated with increased Salmonella infections [48]. This hypothesis was also confirmed in the rodent
model of Salmonella infection. Tennant et al. [49] showed that treatment of mice with antacids resulted
in the decreased infectious dose of Salmonella as compared to normal mice.
Similar results were also observed in a constitutively hypochlorhydric mice (proton pump
mutation) as compared to the normal mice [49]. Additionally, gastric pH not only affects the survival of
pathogens but also affects digestion and absorption of foods. Lucas et al. showed that an increase in pH
from 1.5 to 2.5 reduced digestion of the kiwifruit peptides [50]. Gastric pH also modulates absorption
of micronutrients such as zinc. Henderson et al. observed higher plasma zinc levels in the young
healthy volunteers at low pH as compared to plasma level in higher gastric pH volunteers [51]. The
gastric pH is considerably different across species. For instance, mean gastric pH in mice is 3.1–4.5 and
in rats ranges from 3.2 to 3.9, whereas in the humans it is 1.5–3.5. In addition to gastric pH, intestinal
pH is also different in rodents as compared to humans. Mice and rats have a mean intestinal pH of 5.2
and 6.6, respectively, as compared to 7.2 in humans [52]. These studies show that gastric and intestinal
pH could potentially affect bioactivity of dietary components and should be considered as one of the
important factors in selecting a study model.
In rodents and humans, several disease symptoms can be confounding due to the differences
in their anatomy and physiology. For example, in the non-typhoidal salmonellosis, vomiting and
diarrhea are the main symptoms in humans. However, anatomically mice cannot vomit and due to
this reason, the assessment of diarrhea could be very difficult in mice. In these cases, it becomes harder
to translate the finding into clinical applications. Hence, these limitations of rodent models should
be taken into consideration while interpreting the results from the dietary intervention studies for
Salmonella infections in the rodent models for application in human clinical trials.
2.3. Summary of Effect of Dietary Components on Salmonella Infection in Pig Models
Pigs have been used in several studies involving dietary interventions [53]. Pigs have many
more similarities to the human gastrointestinal tract as compared to rodents. Humans and pigs are
similar in the body composition, cardiovascular, renal, nutritional, immunological, metabolic, and
gastrointestinal aspects [53]. As such, several studies have been conducted in pig models of Salmonella
infection interactions with dietary interventions. Michiels et al. demonstrated that supplementation
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of a mixture of formic, sorbic, and benzoic acid to the piglets for 35 days, significantly reduced the
Salmonella fecal shedding as compared to the control group after oral challenge [54]. Dietary organic
acids increase fecal cytotoxicity to Salmonella, but the effect can be dependent upon the environmental
temperature. Rajtak et al. exhibited that supplementation of a pig diet with organic acid (Potassium-
diformate) reduced the survival of Salmonella in pig feces when incubated at 22 ◦C but not at 4 ◦C [55].
Boyen et al. fed the supplemented diet with the coated butyric acid (2 g/kg of diet) to the pigs for 12 days
and orally challenged the animals with Salmonella [56]. Fecal shedding of Salmonella was decreased
in the coated butyric acids fed animals as compared to the un-coated group. It was hypothesized
that coating prevents the degradation of fatty acids in the intestinal tract [56]. Dietary supplements
also reduced inflammation after Salmonella infection in pigs. Chen et al. supplemented the pig diet
with arginine (0.5%) for 1 week and infected the pigs intramuscularly with Salmonella [57]. Effects of
various essential oils have been similarly reviewed by Omonijo et al. as effective antimicrobials in
Swine production [58].
Fecal Salmonella shedding is one of the distinctive biomarkers of Salmonella infection in pig models.
However, Salmonella colonization patterns are different in pigs as compared to humans. For instance,
Salmonella Typhimurium has been observed to colonize in tonsils and respiratory tissues of infected
pigs [59], whereas in humans, it does not colonize at those sites. The pig stomach is 2–3 times larger
compared to humans [52], this anatomical difference may have impacts on Salmonella survival and
digestibility of dietary components. Pig cecum is also several folds larger than the human cecum and
may have implications in the Salmonella colonization [52]. In humans, stomach pH before eating is
around 5, however, in pigs it is below 2. Consequently, pigs release a much greater extent of bile in the
duodenum as compared to humans. Due to antimicrobial activities, bile could impact colonization of
Salmonella in the proximal small intestine. Additionally, it can modulate digestion and absorption of the
dietary components. Besides these differences, pigs are different in gastrointestinal thickness of mucus,
and gastrointestinal motility and transit, as compared to humans. The distal small intestine of pigs
contains a larger number of microbes as compared to humans and can degrade some carbohydrates
with low digestibility compared to humans [60]. Hence, similar dietary interventions in pigs and
humans may exhibit different potential. The pig immune system also differs from humans, however,
implications of this difference have not been studied in regard to enteric infections. For instance, the
gut of neonate piglets completely lacks leukocytes whereas human infants have a few leukocytes at
birth [61]. Pig intestine contains a larger number of Peyer’s patches as compared to humans throughout
the intestine [61].
2.4. Summary of Effect of Dietary Components on Salmonella Infection in Calf Models
Although there are appreciable differences between monogasters and ruminants, calves develop
very similar clinical and pathological features such as diarrhea and enteritis to human, hence, calves
are considered one of most reliable models to mimic the human non-typhoidal salmonellosis [36].
These similarities have been also discussed by Higginson et al. [62].
After Salmonella infection, the calves show similar clinical symptoms as humans such as fever,
diarrhea, anorexia and dehydration and the intestinal pathological changes [63]. Hill et al. revealed
that feeding of a commercially available blend of butyric acid, coconut oil, and flax oil to the male
Holstein calves for 28 days altered the inflammatory response to intraperitoneal Salmonella toxoid as
compared to the control group [64]. The dietary blend reduced hyperthermia, hypophagia, and serum
TNF-α but increased the IL-4 as compared to the control group [64].
Despite above-mentioned similarities, calves also exhibit significant anatomical and physiological
differences in the digestive system relative to humans. A ruminant’s stomach is four chambered and
contains a large number of microflora that digests fibers, especially cellulose which remain undigested
in humans. Sugars are fermented in ruminant stomach and as a result several volatile fatty acids are
produced [65]. Most of the carbohydrates are converted into volatile fatty acids and a very small
proportion of carbohydrates are absorbed as glucose. Additionally, the ruminant microflora differs
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from the human gut microflora to a great extent [66]. Hence, the same dietary components may
produce different metabolites and physiological effects as compared to humans. Logistically, calves
need a large amount of food and it is very expensive to conduct the dietary experimental studies in
this model.
2.5. Summary of Dietary Interventions for Salmonella Infection in Humans
A variety of Salmonella serovars infect humans. Epidemiological studies have shown that typhoidal
and non-typhoidal salmonellosis are the predominant types of infections [67]. Salmonellosis is clinically
prognosed by headache, diarrhea, constipation, abdominal pain, chills, loss of appetite, and fever with
an incubation time varying from hours to several days [68,69]. Typhoidal salmonellosis is less prevalent
in the United States as compared to other developing countries [67]. In contrast, non-typhoidal
salmonellosis presents a major and persisting public health challenge in North America. From 1998 to
2017, over 2600 single or multi-state non-typhoidal Salmonella outbreaks have occurred in the United
States associated with animal and plant based foods [70]. Symptoms could be self-limiting, lasting
for 1 week without treatment but could also lead to serious complications if left untreated, especially
in immunocompromised subjects and those in at-risk populations [69]. Antimicrobial therapy is the
first choice of treatment in persistent human salmonellosis. However, as discussed in the introduction
section, the problem of drug resistance has become more prevalent due to extensive therapeutic use
of antibiotics in healthcare facilities and subtherapeutic doses during animal food production [71].
Hence, dietary prophylactic interventions could be further utilized for prevention and alleviating
symptoms of Salmonella infections. A few dietary prophylactic studies have been conducted in children
for prevention of Salmonella infections. Stool frequency, vomiting, and Salmonella fecal shedding
are the parameters measured in these clinical trials. Several other disease conditions also affect the
incidence of Salmonella infections. Di Cagno et al. revealed that administration of gluten free diets in
children with celiac disease did not reduce Salmonella shedding from stool as compared to healthy
children [72]. Other dietary interventions are effective in reducing Salmonella infection. Lara et al.
showed that feeding of dairy products containing probiotic mixtures of various strains of Lactobacillus
to healthy children for 6 weeks decreased Salmonella serovars adhesion to the intestinal mucin [73].
Dietary interventions can also reduce frequency of stool and vomiting in Salmonella infected children.
Rabbani et al. revealed that feeding of cooked banana for 1 week in children having persistent diarrhea,
reduced frequency of the stool and vomiting as compared to children fed only with rice diet [74]. In
another clinical trial in children, fermented food (lactic-acid fermented cereal gruel) was fed to healthy
children three times a day for 2 weeks. After 2 weeks of feeding, stool swabs were taken from the
treated and non-treated groups and analyzed for the presence of enteropathogenic bacteria including
Salmonella. The fermented food reduced the presence of enteropathogenic bacteria as compared to the
control diet [75]. These studies show that dietary interventions can be effective in the management of
diarrheal diseases. However, there are several constraints in conducting dietary studies in Salmonella
infections in humans that are prophylactic in nature. In addition to clinical equipoise, the major
issues in conducting human clinical trials are time, cost, availability of appropriate stool and serum
biomarkers and overall patient compliance and ethics. In presence of these curtailments, a dietary
intervention could be pre-clinically evaluated in a relevant animal model to predict the safety and
efficacy of the compound prior to administration in clinical trials [76].
It is noteworthy that bioactive compounds and probiotic diet might have a positive effect on
colonization of Salmonella serovars in gastrointestinal area. As an example, a probiotic diet containing
Enterococcus spp. could lead to increased fecal excreting and colonization of Salmonella in organs of
piglets [77]. The current study is limited to discussing the literature that demonstrates antagonistic
efficacy against colonization of Salmonella serovars, rather than those enhancing proliferation of the
pathogen. Table 1 summarizes the pros and cons of Salmonella models discussed in the current study.
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Table 1. Strengths and weaknesses of Salmonella models discussed in the current study.
Infection Model Strength Weaknesses
Salmonella Culture
(Non-Host)
Direct interaction with the pathogen
without confounders
Does not represent the interaction of
dietary components with the host
Co-culture of Salmonella
with host cell
Increased complexity of interaction
compared to only pathogen culture,
represents effects of intervention on the
pathogen as well as the host
Does not represent involvement of all
the host cell types that simultaneously
happen together in human
Rodent Models
Represent a complex living system, very
economical and convenient, ease in
genetic manipulation to know
mechanistic pathways
No diarrhea and vomiting, different
intestinal immunity, different gastric
environment, and anatomical structures
Pig Models




Different than humans in Salmonella
colonization pattern, gastric acidity, bile
quantities, mucus thickness, immune
system, not economical, not convenient
Calf Models
Develop similar clinical and
pathological features such as diarrhea
and enteritis
Stomach structure is different, not
economical
Clinical Trials The ideal model
Difficult to study the preventive effects
of interventions due to ethical
considerations
3. Potential Mechanisms of Protection against Salmonella Infections
3.1. Alteration in Bile Quality and Quantity
Bile is an important digestive fluid synthesized by the liver of many vertebrates. Bile plays a role
in digestion of fats in small intestine by emulsification, micelle formation. As a result, absorption of
fat-soluble vitamins such as vitamin A, D, E, and K is also increased in the presence of bile. Bile is stored
in the gall bladder and released into the duodenum after receiving stimuli in the form of semi-digested
fats and proteins from stomach. After digestion of fats, the majority of the bile is reabsorbed in terminal
ileum. Cholycystokinin and secritin hormones in the gut control this process. Bile is alkaline and
composed of phospholipids, bile acids, and surfactants. In the duodenum alkaline pH neutralizes
stomach acid [78].
In addition to digestive role of bile, it exhibits an antimicrobial role against gastrointestinal
pathogens [79]. Both bile quality and bile quantity may determine the multiplication of enteric
pathogen [80]. Bile salts have been shown to act as antimicrobials especially on Salmonella and other
enteric infections [81,82]. Different dietary fibers have been shown to affect bile composition to different
extent and to improve colonization resistance against enteric pathogens [83]. Inagaki et al. showed
that bile acids induces genes involved in enteroprotection by inhibiting pathogenic overgrowth and
mucosal injury in the ileum in a mouse model of infection [84]. Diet consists of several compounds
of plant and animal origin and hence considered as a multi-targeting intervention for prevention of
enteric infection. Xu et al. [85] showed that consumption of dietary medium chain fatty acids increased
fecal bile acids (cholic acid) significantly as compared to control group in C57BL/6J Mice. Kollanoor et
al. demonstrated that feeding of Caprylic acid (a medium chain fatty acid) to poultry significantly
reduced Salmonella infection in the intestine as well in organs therapeutically [83]. Further, in vitro
study in hepatocytes showed that addition of medium chain fatty acids in culture media enhances cell
surface expression and transport capacity of bile salt export pump (BSEP/ABCB11) [86]. Costarelli et
al. compared diets containing different fatty acids in healthy premenopausal women and found that
dietary linoleate increased postparandial plasma bile acid and cholycytokinin as compared to low fat
diet [87]. Dietary fish oil increased fecal bile acids in a rodent model without increased gene expression
for bile synthesis in the liver [88]. This study suggests although not all fatty acids increase bile acid
synthesis in the liver, some could reduce bile absorption in the ileum. Studies have further exhibited
that the change in bile acid release alters pH of the intestine and affects Salmonella adherence and
survival. Several Salmonella genes are affected in the presence or absence of bile. Both bile quality and
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quantity have been shown repress Salmonella virulence in gut environment in in vivo models [89–91].
Antunes et al. [92] showed that Salmonella could multiply in the gall bladder of susceptible mice
and causes typhoid. Bile acids exert antimicrobial actions on pathogens by virtue of their detergent
properties. Cholic and deoxycholic acids in bile can damage bacterial DNA [79].
Dietary factors such as fiber may bind to bile acids and reduce reabsorption in colon [93]. Oat
bran, pectin, and guar gum have been shown to increase bile acids in fecal matter [94–96]. Reduction
in reabsorption of bile acids in the large intestine modulates the gut hormone feedback system and
stimulates the liver to synthesize more bile acids [78]. This process could reduce alkalinity of the small
intestine, and may increase gut motility, making the gut environment unfit for Salmonella infection [97].
3.2. Gut Mucosa
In order to reach epithelium, Salmonella needs to cross luminal barriers. Intestinal mucous is the
first line of defense to Salmonella in the small intestine of rodents and humans [98]. Mucus in the small
intestine is single layered and loosely attached to epithelium as compared to double-layered mucus of
colon. Mucous is made up of secretory proteins called mucins and the predominant mucin in small
intestine is Muc2 [99]. Abnormalities in mucous layers, underproduction of Muc2 by goblet cells
and mutated Muc2 results in elevated risk for bacterial infection [100]. A study shows that during
Salmonella infection, the mucin layer is disrupted and Salmonella obtain access to epithelium [101].
Various components of diet have been shown to upregulate expression of Muc2 in intestinal cells.
Willemsen et al. showed that treatment of intestinal epithelial and fibroblast co-culture with short
chain fatty acids significantly increased expression of Muc2 [102]. Ingestion of dietary fibers (soluble
and insoluble) has been shown to increases proliferation of goblet cells and sialylated mucin in the
small intestine of rats [103]. In another study, feeding of inulin/fructans in a rodent trial significantly
increases mucous layer thickness in the colon and increases the number of goblet cells in crypts of
distal jejunum as compared to control diet [104]. Morita et al. similarly exhibited that intake of dietary
resistant starch in rodents reduces endotoxin influx from intestinal tissue and hypothesized that it
could be partially due to alterations in mucosal barrier functions [105].
3.3. Antimicrobial Activities
After crossing the mucin layer in the gut, enteric pathogens need to penetrate epithelial layer
in order to infect the organism. Human gut epithelia consist of a monolayer of epithelial cells. It
separates the gut lumen from the lamina propria. Intestinal epithelial cellular junctions affect intestinal
permeability as well as transcytosis capacity of individual cells. Strong cellular junctions are necessary
to avoid the invasion of pathogens through epithelium. Salmonella can breach the epithelial barrier by
employing para-cellular and trans-cellular mechanisms, including actin cytoskeleton of the epithelial
cells and the secretion of the effector molecules [30].
Dietary components have been discussed in the past as factors to modulate the epithelial
barrier [106]. Diet can have both positive and negative impacts on epithelial integrity. Liu et al. showed
that when a high grain diet was fed to male goats, it resulted in the disruption of the ruminal epithelium
as measured by the presence of systemic lipopolysacharide (LPS) [107]. However, diet can also impact
epithelial integrity positively. In a study by Nofrarias et al., pigs were fed resistant starch for 97 days
and consequently increased hypertrophy, reduced apoptosis in the crypts, lymphoid nodules in the
colon, and increased mucin sulfuration were observed. These changes promoted epithelial protection
compared to the control dietary group containing digestible starch [108]. Dietary components can also
modulate the epithelial proteins such as occludins that secure junctions between the adjacent cells in
the gut epithelium. Enteric pathogenic bacteria secrete LPS that causes inflammation and escalates loss
of protein occludin that decreases the barrier function of epithelium. Park et al. showed in a rodent
trial that dietary administration of gangliosides (a lipid) prevents LPS induced degradation of the
occludin and reduces the total nitric oxide in the gut mucosa [109]. An in vitro study with Caco-2
cells demonstrated that addition of quercetin (a flavonoid) induces expression of zonula occludens-2,
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occludin, and claudin-1 and claudin-4 as compared to the control group [110]. All of these proteins
play an important part in maintaining epithelial integrity. Salmonella entry into epithelial cells can
result in epithelial necrosis and apoptosis. Int-407 cell line (human intestinal cell line) showed a
significantly lesser extent of necrosis and apoptosis during Salmonella infection when treated with
sterols and fatty acids found in the root extract of Hemidusmus indicus as compared to an untreated
cell line [111]. Hence, protection of the epithelium can be considered an important target of dietary
interventions in Salmonella infections.
3.4. Gut Microbiome
The gut contains more than a trillion symbiotic bacteria that play a major role in developing
immunity as well as resistance against enteric infections. Initially it was hypothesized that the genetic
factors were responsible for susceptible and resistant mouse strains against the enteric infections.
However, currently literature delineates that the genetic factors are only one of the determinants of
composition and structure of the gut microflora. As an example, Willing et al. successfully transferred
the microbiota from resistant to susceptible mice and observed a delayed colonization of Citrobacter
rodentium and mortality in susceptible strain [112]. In the same study, native gut microbiota of resistant
mice was depleted by oral streptomycin (20 mg) 24 h prior to transplantation and replaced by the
microbiota from susceptible mice. As a result, the oral antibiotic treatment reduced the innate defenses
and a severe infection pathology was observed as compared to mice in control group. This experiment
demonstrates that gut microbiota plays an important role in fighting the infection [112]. Similarly,
mice were given a combination of antibiotics (Streptomycin, Vancomycin, Ampicillin, Neomycin, and
Metronidazole) for 1 week in drinking water and later orally challenged with Salmonella Typhimurium
14028. The mice on the antibiotics showed a significantly higher number of Salmonella DNA in the
cecum and large intestine as compared to control mice group [113]. The gut microbiota may affect
enteric infections by modulating the intestinal immunity or by the direct competition. Symbiotic
gut microbiota competes with pathogens for the nutrients such as iron and carbon sources [114].
Stelter et al. showed that Salmonella-induced mucosal lactins kills symbiotic gut microflora and then
Salmonella takes advantage of this process for survival in gastrointestinal tract [115]. Salmonella induces
acute inflammation in mice and neutrophils are recruited at the site of infection. Gill et al. showed
that neutrophil elastases can shift mice gut microbiota and increase Salmonella colonization, while
neutralization of neutrophil elastases decrease colonization of Salmonella [116]. These studies show
that gut microbiota play an important role in protection from Salmonella infections and modulation of
gut microflora for prevention of enteric infections warrants further studies.
Given the role of gut microbiota in protection against Salmonella, several studies have been
conducted to test effects of dairy and native gut probiotics on Salmonella colonization. Probiotics are
the microorganisms that induce health benefits when consumed in effective doses. Lactobacillus and
Streptococcus are two widely studied categories of probiotics and their effectiveness against Salmonella
is articulated by Castillo et al. [117]. Lactobacillus rhamnosus has been shown to reduce Salmonella
adhesion to epithelial cells in in vitro model of Salmonella infection [118]. Probiotics not only compete
with Salmonella for nutrients but also enhance protective immunity against the pathogen. Castillo
et al. showed that oral administration of Lactobacillus in mice changes cytokine production and Toll
Like Receptor (TLR) expression that is protective for mice against Salmonella infection [119]. Moreover,
probiotics such as Bifidobacterium can directly affect virulence of Salmonella by releasing the molecules
that down-regulate the expression of pathogenicity islands 1 and 2 [120]. Hence, Lactobacillus and
Bifidobacterium have emerged as potential contributors for protection against enteric infections such as
Salmonella serovars.
Diet is a major factor in the establishment of gut microbiome. As an example, previous studies
exhibit that a change of diet from low-fat, high plant-based polysaccharide to the high-fat, and
high simple sugar diet, could change structure of the gut microbiota very rapidly [121]. A shift of
low-fat diet to the Western diet also changes metabolic pathways and modulates gene expression
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in gut microbiome [122]. Humanized mice (mice transplanted with human gut microflora) when
fed a Western-type diet, showed an increased adiposity and this trait was transmissible through the
transplantation of the gut microbiota in other mice [122]. Diet could also modulate gut microbiota
directly by providing prebiotics—many studies have exhibited the efficacy of the prebiotics such as
dietary fiber, fatty acids, and polyphenols for a shift in gut microflora [123,124].
3.5. Gut Immunity
The immune system of the gastrointestinal tract is the largest segment of the mammalian immune
system. The gut encounters massive amounts of pathogens and dietary antigens that need to be
neutralized. These functions emphasize the importance of gut immune system. The mucosal immune
system is equipped with innate and adaptive immune defense mechanisms. Innate immunity provides
the first line of defense against pathogens. The major players of the innate immune defense are
macrophages, monocytes, neutrophils, epithelial cells, natural killer (NK) cells, and dendritic cells
(DCs) [125]. Dendritic cells, macrophages, and epithelial cells are also termed as antigen presenting
cells (APCs) because of their capacity of processing and presenting foreign antigens to other cells.
APCs have a series of receptors called Pattern Recognition Receptors (PRRs) on their surfaces such as
TLRs and Nod Like Receptors (NODs) to recognize the pathogens [126]. These receptors recognize
motifs on pathogens known as the Pathogen Associated Molecular Patterns (PAMPs) [127]. The innate
immune cells release inflammatory cytokines and mediators after sensing the PAMPs [128]. However,
if innate immunity fails to resolve the inflammation and eliminate pathogen, adaptive immunity enters
this process. In the gut adaptive immune system, the predominant response is antibody mediated
and is represented by the Immunoglobulin A (IgA) [129]. The IgA is chiefly produced by the B cells
in the intestinal mucosa triggered by anti-inflammatory cytokines such as TGF-β and IL-10 [130].
Hence, both innate and adaptive immune responses are required in the protection against infection
and depends upon type of pathogen.
The role of the gut immune system in protection from enteric infections has been studied
intensely [131–133]. Primary Salmonella infection increases interferon gamma (IFN-γ), tumor necrosis
factor alpha (TNF-α), and interleukin 12 (IL-12) in circulation and in local tissues [133–135]. Major
sources of IFN-γ and TNF-α are neutrophils and macrophages [136]. IL-12 is a cytokine induced in
response to several bacteria and mediates onset of the Th1 protective response. Natural killer T (NKT)
cells produce IFN-γ in response to IL-12 [137]. Infected macrophages also interact with NK cells in
order to produce IFN-γ in humans [138]. Even though initial innate immune response restricts infection
to a certain extent, it fails to inhibit multiplication of pathogens in deeper tissues. Hence, immune
response is switched to adaptive response after some time and is achieved mainly by induction of
CD4+ T cells, CD8+ T cells, and B cells [139]. In experimental models, depletion of CD4+ T cells
had a more pronounced effect on protection from Salmonella as compared to CD8+ T cells. However,
underlying mechanisms are not clear. The second major adaptive response to Salmonella is induction
of the B cells to produce antibodies such as IgA. The antibodies bind Salmonella and prevent entry
into deeper tissues. Administration of B cell hybridoma producing Salmonella specific IgA has been
shown to prevent oral Salmonella infection in the mice [140]. These studies exhibited the potentially
appreciable role of bioactive compounds for augmenting host immunity against Salmonella infections.
Dietary components such as dietary fiber and prebiotics manipulate both the innate and adaptive
immunity [141]. Galdeano et al. demonstrated that feeding of probiotic fermented milk to the
rats increases the number of macrophages and DCs with an increase in IFN-γ, TNF-α, and IL-12
after 5 days of nutrition [142]. Nutrients such as glutamine, arginine, vitamin A, and zinc have
protective impacts against enteric infections [143]. Macrophages play an important role in clearance of
Salmonella in primary infections. Modified arabinoxylan rice bran improves the phagocytic function
of macrophages in the in vitro models of RAW264.7 cells [144]. Treatment of macrophages with the
modified arabinoxylan rice bran increased the attachment and phagocytosis of yeast cells with an
increase in TNF-α and IL-6 [144]. Wang et al. showed an enhanced Salmonella specific immune response
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in the orally vaccinated mice with attenuated Salmonella and fed with white button mushroom powder
as compared to the only vaccinated mice [145]. The white button mushroom fed mice had higher
number of Salmonella specific fecal IgA, IFN-γ, and TNF-α in splenocytes. These mice also showed
an increased number of DCs and activation marker CD40 in splenocytes as compared to the control
mice [145]. These studies show that dietary interventions could modulate pro-inflammatory responses
and manipulate the innate and adaptive immunity [141].
4. Conclusions
Various dietary components could have considerable efficacy on prevention of Salmonella serovars
infections. These effects may involve various mechanisms through impacting the gastrointestinal
microbiota, immune system, and epithelium. The efficacy of various bioactive compounds for inhibiting
the proliferation of Salmonella serovars in various in vitro, in vivo, animal models, and randomized
studies reviewed creates the opportunity of mitigating the burden of Salmonellosis through dietary
intervention. Despite striking similarities, animal models have major differences with human anatomy,
as such delineated differences should be considered diligently for interpretation of these studies.
Clinical equipoise, cost, time, and other ethical issues are also major curtailments for further conduct
of randomized clinical trials with human subjects. The vast majority of the discussed literature
demonstrate efficacy and mechanism of action of a sole bioactive compound. Pre-clinical studies
investigating synergism and/or antagonistic activities of an array of bioactive compounds, additional
randomized clinical trials, and well-planned epidemiological studies with comprehensive plans for
control of confounders could augment the development of a validated and evidence-based guideline
for mitigating the public health burden of human Salmonellosis through dietary compounds.
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